Imunon, Inc. — Investor Relations & Filings
Filings indexed
1,030
across all filing types
Latest filing
2026-05-12
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
IMNN
Imunon, Inc. is a clinical-stage biotechnology company that develops novel immunotherapies and DNA-based vaccines. The company's core focus is on creating treatments for challenging conditions, including cancer and infectious diseases, by harnessing the patient's immune system. Its proprietary technology platforms are centered on immunology and nucleic acid-based therapies. The lead candidate in its pipeline is IMNN-001, a DNA-based immunotherapy in clinical development for advanced ovarian cancer. Imunon oversees the complete drug development lifecycle, from initial research and discovery to manufacturing in its in-house GMP-compliant facility.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Imunon, Inc. (0000749647) (Filer) | 2026-05-12 | English | |
| 8-K - Imunon, Inc. (0000749647) (Filer) | 2026-05-12 | English | |
| ARS | 2026-05-04 | English | |
| 8-K - Imunon, Inc. (0000749647) (Filer) | 2026-05-04 | English | |
| DEF 14A - Imunon, Inc. (0000749647) (Filer) | 2026-05-04 | English | |
| 10-K - Imunon, Inc. (0000749647) (Filer) | 2026-03-31 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45268326 | 10-Q - Imunon, Inc. (0000749647) (Filer) | 2026-05-12 | English | ||
| 45254021 | 8-K - Imunon, Inc. (0000749647) (Filer) | 2026-05-12 | English | ||
| 46087394 | ARS | 2026-05-04 | English | ||
| 40890001 | 8-K - Imunon, Inc. (0000749647) (Filer) | 2026-05-04 | English | ||
| 40862043 | DEF 14A - Imunon, Inc. (0000749647) (Filer) | 2026-05-04 | English | ||
| 33115423 | 10-K - Imunon, Inc. (0000749647) (Filer) | 2026-03-31 | English | ||
| 33114912 | 8-K - Imunon, Inc. (0000749647) (Filer) | 2026-03-31 | English | ||
| 33016221 | 8-K - Imunon, Inc. (0000749647) (Filer) | 2026-03-23 | English | ||
| 46087397 | 424B5 | 2026-03-23 | English | ||
| 30315846 | SCHEDULE 13G - Imunon, Inc. (0000749647) (Subject) | 2026-02-18 | English | ||
| 18414230 | 8-K Filing | 2026-02-05 | English | ||
| 18414256 | 3 Filing | 2026-01-20 | English | ||
| 18414246 | 8-K Filing | 2026-01-07 | English | ||
| 18414287 | 4 Filing | 2026-01-06 | English | ||
| 18414279 | 4 Filing | 2026-01-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Asymchem Laboratories (Tianjin) Co., Ltd.
A leading CDMO providing comprehensive, integrated pharmace…
|
6821 | HK | Manufacturing |
|
Asymchem Laboratories (Tianjin) Co., Ltd.
Global CDMO providing integrated CMC services across the dr…
|
002821 | CN | Manufacturing |
|
ATAI Life Sciences N.V.
Develops psychedelic-inspired therapies for mental health d…
|
ATAI | NL | Manufacturing |
|
Atea Pharmaceuticals, Inc.
Clinical-stage biopharma developing oral antiviral therapie…
|
AVIR | US | Manufacturing |
|
Athira Pharma, Inc.
Biopharma firm developing small molecule therapeutics for n…
|
ATHA | US | Manufacturing |
|
Atlas Global Brands Inc.
Global cannabis company spanning cultivation, manufacturing…
|
ATL | CA | Manufacturing |
|
ATOSSA THERAPEUTICS, INC.
Clinical-stage biopharmaceutical company developing oncolog…
|
ATOS | US | Manufacturing |
|
Atrium Innovations Inc.
Develops, manufactures, and sells science-based natural hea…
|
ATB | CA | Manufacturing |
|
Atrium Therapeutics, Inc.
Pioneering precision RNA medicines for cardiac diseases, fo…
|
RNA | US | Manufacturing |
|
aTYR PHARMA INC
Develops medicines based on tRNA synthetase biology for fib…
|
ATYR | US | Manufacturing |
Imunon, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35124/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35124 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35124 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35124 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35124}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Imunon, Inc. (id: 35124)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.